Lotus Bio-Technology Development's total assets for Q3 2018 were $55.46K, an increase of Infinity% from the previous quarter. LBTD total liabilities were $116.77K for the fiscal quarter, a 43.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
